Diabetes Secondary to Acromegaly: Physiopathology, Clinical Features and Effects of Treatment
出版年份 2018 全文链接
标题
Diabetes Secondary to Acromegaly: Physiopathology, Clinical Features and Effects of Treatment
作者
关键词
-
出版物
Frontiers in Endocrinology
Volume 9, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2018-07-06
DOI
10.3389/fendo.2018.00358
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Somatostatin Analogs and Glucose Metabolism in Acromegaly: A Meta-Analysis of Prospective Interventional Studies
- (2018) Alessia Cozzolino et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Novel Somatostatin Receptor Ligands Therapies for Acromegaly
- (2018) Rosa Maria Paragliola et al. Frontiers in Endocrinology
- MANAGEMENT OF ENDOCRINE DISEASE: Risk of overtreatment in patients with adrenal insufficiency: current and emerging aspects
- (2017) G Mazziotti et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- High-Dose and High-Frequency Lanreotide Autogel in Acromegaly: A Randomized, Multicenter Study
- (2017) Andrea Giustina et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Efficacy and Safety of Switching to Pasireotide in Patients With Acromegaly Controlled With Pegvisomant and First-Generation Somatostatin Analogues (PAPE Study)
- (2017) Ammar Muhammad et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A multicenter, observational study of lanreotide depot/autogel (LAN) in patients with acromegaly in the United States: 2-year experience from the SODA registry
- (2017) Roberto Salvatori et al. Pituitary
- Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities
- (2017) Rosario Pivonello et al. Pituitary
- The association between biochemical control and cardiovascular risk factors in acromegaly
- (2017) John D. Carmichael et al. BMC Endocrine Disorders
- Pegvisomant in acromegaly: an update
- (2017) A. Giustina et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Glucose and lipid levels with lanreotide autogel 120 mg in treatment-naïve patients with acromegaly: data from the PRIMARYS study
- (2016) Philippe J. Caron et al. CLINICAL ENDOCRINOLOGY
- What is the efficacy of switching to weekly pegvisomant in acromegaly patients well controlled on combination therapy?
- (2016) A Muhammad et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Acromegaly incidence, prevalence, complications and long-term prognosis: a nationwide cohort study
- (2016) Jakob Dal et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- The Mexican Acromegaly Registry: Clinical and Biochemical Characteristics at Diagnosis and Therapeutic Outcomes
- (2016) Lesly A. Portocarrero-Ortiz et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Monotherapy with lanreotide depot for acromegaly: long-term clinical experience in a pituitary center
- (2016) Babak Torabi Sagvand et al. Pituitary
- Epidemiology of acromegaly: review of population studies
- (2016) Aikaterini Lavrentaki et al. Pituitary
- Metabolic syndrome and hypogonadism – two peas in a pod
- (2016) F Ebrahimi et al. SWISS MEDICAL WEEKLY
- Current and Emerging Aspects of Diabetes Mellitus in Acromegaly
- (2016) Stefano Frara et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Switching patients with acromegaly from octreotide to pasireotide improves biochemical control: crossover extension to a randomized, double-blind, Phase III study
- (2016) Marcello D. Bronstein et al. BMC Endocrine Disorders
- The prevalence of acromegaly in hospitalized patients with type 2 diabetes
- (2015) Kentaro Suda et al. ENDOCRINE JOURNAL
- Adverse events associated with somatostatin analogs in acromegaly
- (2015) Ludovica FS Grasso et al. Expert Opinion On Drug Safety
- Serum visfatin levels in acromegaly: Correlation with disease activity and metabolic alterations
- (2015) A. Ciresi et al. GROWTH HORMONE & IGF RESEARCH
- 60 YEARS OF NEUROENDOCRINOLOGY: Acromegaly
- (2015) Cristina Capatina et al. JOURNAL OF ENDOCRINOLOGY
- Safety of long-term treatment with Pegvisomant: analysis of Spanish patients included in global ACROSTUDY
- (2015) I. Bernabeu et al. Pituitary
- Italian Society for the Study of Diabetes (SID)/Italian Endocrinological Society (SIE) guidelines on the treatment of hyperglycemia in Cushing’s syndrome and acromegaly
- (2015) M. G. Baroni et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Does pegvisomant treatment expertise improve control of resistant acromegaly? The Italian ACROSTUDY experience
- (2015) S. Cannavo et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- The Role of Diabetes in Acromegaly Associated Neoplasia
- (2015) Sonia Cheng et al. PLoS One
- Therapy of acromegalic patients exacerbated by concomitant type 2 diabetes requires higher pegvisomant doses to normalise IGF1 levels
- (2014) Michael Droste et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Acromegaly: An Endocrine Society Clinical Practice Guideline
- (2014) Laurence Katznelson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pasireotide Versus Octreotide in Acromegaly: A Head-to-Head Superiority Study
- (2014) A. Colao et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The impact of transsphenoidal surgery on glucose homeostasis and insulin resistance in acromegaly
- (2014) Maria Stelmachowska-Banaś et al. Neurologia i Neurochirurgia Polska
- Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial
- (2014) Mônica R Gadelha et al. Lancet Diabetes & Endocrinology
- Prevalence of diabetes mellitus in patients with acromegaly
- (2014) A V Dreval et al. Endocrine Connections
- Management of hyperglycemia associated with pasireotide (SOM230): Healthy volunteer study
- (2013) Astrid Breitschaft et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Effects of medical therapies for acromegaly on glucose metabolism
- (2013) C Urbani et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Hyperglycemia Associated With Pasireotide: Results From a Mechanistic Study in Healthy Volunteers
- (2013) Robert R. Henry et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Short-Term Administration of Pegvisomant Improves Hepatic Insulin Sensitivity and Reduces Soleus Muscle Intramyocellular Lipid Content in Young Adults With Type 1 Diabetes
- (2013) A. Thankamony et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Tumor Shrinkage With Lanreotide Autogel 120 mg as Primary Therapy in Acromegaly: Results of a Prospective Multicenter Clinical Trial
- (2013) Philippe J. Caron et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Prevalence and risk factors of impaired glucose tolerance and diabetes mellitus at diagnosis of acromegaly: a study in 148 patients
- (2013) Orsalia Alexopoulou et al. Pituitary
- Metabolic Glucose Status and Pituitary Pathology Portend Therapeutic Outcomes in Acromegaly
- (2013) Sonia Cheng et al. PLoS One
- Predictors of morbidity and mortality in acromegaly: an Italian survey
- (2012) M Arosio et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Prevalence of diabetes mellitus in 6050 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis
- (2012) Roger Abs et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Long-term outcome in patients with acromegaly: analysis of 1344 patients from the German Acromegaly Register
- (2012) Christof Schöfl et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Visceral Adiposity Index Is Associated with Insulin Sensitivity and Adipocytokine Levels in Newly Diagnosed Acromegalic Patients
- (2012) A. Ciresi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effective Combination Treatment with Cabergoline and Low-Dose Pegvisomant in Active Acromegaly: A Prospective Clinical Trial
- (2012) C. E. Higham et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Metabolic Profile in Active Acromegaly is Gender-Specific
- (2012) A. Ciresi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Randomized pilot study of cabergoline, a dopamine receptor agonist: effects on body weight and glucose tolerance in obese adults
- (2011) C. D. Gibson et al. DIABETES OBESITY & METABOLISM
- Impaired glucose metabolism in Japanese patients with acromegaly is restored after successful pituitary surgery if pancreatic β-cell function is preserved
- (2011) Yuka Kinoshita et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Effects of high-dose octreotide LAR on glucose metabolism in patients with acromegaly inadequately controlled by conventional somatostatin analog therapy
- (2011) Gherardo Mazziotti et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Diabetes in acromegaly, prevalence, risk factors, and evolution: data from the French Acromegaly Registry
- (2011) Sandrine Fieffe et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Effects of somatostatin analogs on glucose homeostasis in rats
- (2011) Herbert A Schmid et al. JOURNAL OF ENDOCRINOLOGY
- Glucose status in patients with acromegaly receiving primary treatment with the somatostatin analog lanreotide
- (2011) Elisabeth Couture et al. Pituitary
- Clinical and metabolic effects of first-line treatment with somatostatin analogues or surgery in acromegaly: a retrospective and comparative study
- (2011) Carla Giordano et al. Pituitary
- Increased prevalence of restless legs syndrome in patients with acromegaly and effects on quality of life assessed by Acro-QoL
- (2011) S. Cannavò et al. Pituitary
- Bromocriptine Mesylate for Glycemic Management in Type 2 Diabetes Mellitus
- (2010) Jessica L Kerr et al. ANNALS OF PHARMACOTHERAPY
- Increased prevalence of acromegaly in a highly polluted area
- (2010) S Cannavò et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Frequency of acromegaly in adults with diabetes or glucose intolerance and estimated prevalence in the general population
- (2010) Pedro Weslley Rosario Pituitary
- Clinical and biochemical characteristics of acromegalic patients with different abnormalities in glucose metabolism
- (2010) Ana Laura Espinosa-de-los-Monteros et al. Pituitary
- Age and sex as predictors of biochemical activity in acromegaly: analysis of 1485 patients from the German Acromegaly Register
- (2009) S. Petersenn et al. CLINICAL ENDOCRINOLOGY
- Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006: acromegaly remains under-recognized and under-diagnosed
- (2009) Tirissa J. Reid et al. CLINICAL ENDOCRINOLOGY
- Effects of Growth Hormone on Glucose, Lipid, and Protein Metabolism in Human Subjects
- (2009) Niels Møller et al. ENDOCRINE REVIEWS
- ACROSTUDY: the first 5 years
- (2009) Peter J Trainer EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Glucose Tolerance and Somatostatin Analog Treatment in Acromegaly: A 12-Month Study
- (2009) Annamaria Colao et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pegvisomant Improves Insulin Sensitivity and Reduces Overnight Free Fatty Acid Concentrations in Patients with Acromegaly
- (2009) C. E. Higham et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of Somatostatin Analogs on Glucose Homeostasis: A Metaanalysis of Acromegaly Studies
- (2009) Gherardo Mazziotti et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Lower Visceral and Subcutaneous but Higher Intermuscular Adipose Tissue Depots in Patients with Growth Hormone and Insulin-Like Growth Factor I Excess Due to Acromegaly
- (2008) Pamela U. Freda et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Function and expression of somatostatin receptors of the endocrine pancreas
- (2008) Mathias Z. Strowski et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now